Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

769
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
769
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

1.4K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.4K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

713
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
713
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

8.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.5K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

784
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
784
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

6.2K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissociable somatotopic representations of Chinese action verbs in the motor and premotor cortex.

Scientific reports·2013
Same author

High quantum-yield CdSexS1-x/ZnS core/shell quantum dots for warm white light-emitting diodes with good color rendering.

Nanotechnology·2013
Same author

A novel microfluidic mixer based on dual-hydrodynamic focusing for interrogating the kinetics of DNA-protein interaction.

The Analyst·2013
Same author

Correlation of reorientational jumps of water molecules in bulk water.

Physical review. E, Statistical, nonlinear, and soft matter physics·2013
Same author

Palladium-catalyzed direct arylation of C-H bond to construct quaternary carbon centers: the synthesis of diarylfluorene.

Organic letters·2013
Same author

Strength and fracture behavior of graphene grain boundaries: effects of temperature, inflection, and symmetry from molecular dynamics.

Physical chemistry chemical physics : PCCP·2013

Related Experiment Video

Updated: Mar 7, 2026

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

1.2K

Metformin and thyroid disease.

Xianghui Meng1, Shuhang Xu2, Guofang Chen2

  • 1Chinese Medicine Hospital in Linyi CityLinyi, China.

The Journal of Endocrinology
|February 16, 2017
PubMed
Summary
This summary is machine-generated.

Metformin may help manage thyroid conditions. This drug, used for diabetes, shows potential in reducing thyroid size, nodules, and cancer risk by impacting key cellular pathways.

Keywords:
metforminthyroid cancerthyroid diseasethyroid nodulethyrotropin

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Related Experiment Videos

Last Updated: Mar 7, 2026

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

1.2K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Area of Science:

  • Thyroidology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Insulin resistance is increasingly linked to thyroid abnormalities, including larger thyroid glands and higher risks of nodules and cancer.
  • Hyperinsulinemia, a state of excess insulin, correlates with these adverse thyroid outcomes.
  • Metformin, a common diabetes medication, has shown potential protective effects on the thyroid.

Purpose of the Study:

  • To review the association between insulin resistance, metformin use, and thyroid health.
  • To explore the mechanisms by which metformin may influence thyroid function and morphology.
  • To assess metformin's potential as a therapeutic agent for thyroid diseases.

Main Methods:

  • Review of in vitro and in vivo studies investigating metformin's effects on thyroid cells and cancer cells.
  • Analysis of clinical data on metformin's impact on thyroid volume, nodules, and cancer incidence.
  • Examination of metformin's influence on serum thyroid-stimulating hormone (TSH) levels in diabetic patients.

Main Results:

  • Metformin treatment is associated with smaller thyroid volume and reduced risk of goiter, nodules, and thyroid cancer.
  • In vitro and in vivo studies demonstrate metformin's ability to inhibit thyroid cell and thyroid cancer cell growth via insulin/IGF1 and mTOR pathways.
  • Metformin use correlates with decreased serum TSH levels in diabetic patients, potentially through enhanced thyroid hormone effects and AMPK activation.

Conclusions:

  • Metformin exhibits promising therapeutic potential for managing thyroid diseases, particularly those associated with insulin resistance.
  • Further clinical studies are warranted to confirm metformin's efficacy and clinical significance in treating various thyroid conditions.
  • The drug's multifaceted effects on cellular pathways and hormone regulation highlight its potential role in thyroidology.